Matthew J Oborski

Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2013, Clinical nuclear medicine.